Catalyst Wire Dossier Catalyst Wire Dossier

Bezlotoxumab

bezlotoxumab · Merck & Co.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Bezlotoxumab, covering 2010-09-10 to 2026-06-18. Get the full timeline:

Most recent: Clinical Trial Results: Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery. [Phase 4]

See pricing